$1M Donation to Support Health Equity

DF Sanofi and Regeneron Diversity, Equity and Inclusion Mid-Career Research Award

September 2023

Sanofi and Regeneron $1M donation supports health equity
From left: Dr. Jonathan Weiss, DF Board member; Deb Sierka, PharmD, Sanofi; Andrew Korotzer, PhD, Regeneron; Dr. Valerie Harvey, Immediate Past President SOCS; and Dr. Janet Fairley, DF President
Print Friendly, PDF & Email

The Foundation and the Skin of Color Society (SOCS) have teamed up to create a new research funding opportunity to advance health equity in the specialty. The new research award will support investigative work that expands our understanding of dermatologic issues faced by underrepresented or underserved groups in medicine.

A $1-million sponsorship from Sanofi and Regeneron has enabled the Foundation to enrich its Research Award Program with a DF Sanofi and Regeneron Diversity, Equity, and Inclusion Mid-Career Research Award (SRDEI). The DF and SOCS partnership will deliver on its aim to provide a critical funding option for investigators working to address healthcare disparities.

“Research programs need to reflect the changing demographics of the United States,” said DF President Janet A. Fairley, MD. “I believe the award can be transformative in supporting the next generation of clinical, translational, and basic researchers in this critical area.”

The DF SRDEI award will fund the research of three exceptional mid-career investigators working in DEI-related research with an established trajectory of excellence in basic, clinical, or translational science. Starting in 2024, each recipient will receive $100,000 in annual funding over three years.

Applications for the DF DEI award are due before December 1. Award recipients are announced at the DF Annual Meeting of Membership.

Apply today for a 2024 DF DEI Research Award.